SCHEMBL15538433

SCHEMBL15538433

O=C(O)c1ccc(-c2cnc(OCC3CCN(CC4(C(F)(F)F)CCC4)CC3)nc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.44
ACHE P22303 3/20 0.40
GPR119 Q8TDV5 3/20 0.40
WNT1 P04628 5/20 0.39
GSK3B P49841 5/20 0.39
DYRK1A Q13627 5/20 0.39
KCNH2 Q12809 2/20 0.39
HTR4 Q13639 1/20 0.39
SSTR5 P35346 1/20 0.39
RBP4 P02753 1/20 0.35
TTR P02766 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
XDH P47989 1/20 0.34
DGAT1 O75907 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15539838 0.96 MAP4K4 (0.41) MAP4K4ACHEGPR119WNT1GSK3B
SCHEMBL15539993 0.90 WNT1 (0.41) ACHEGPR119WNT1GSK3BDYRK1A
SCHEMBL15539432 0.90 MAP4K4 (0.43) MAP4K4ACHEGPR119WNT1GSK3B
SCHEMBL15539250 0.88 SSTR5 (0.49) MAP4K4KCNH2SSTR5
SCHEMBL15538762 0.88 MAP4K4 (0.43) MAP4K4ACHEGPR119WNT1GSK3B
SCHEMBL15539646 0.88 RBP4 (0.39) MAP4K4ACHEGPR119WNT1GSK3B
SCHEMBL15538542 0.87 MAP4K4 (0.43) MAP4K4ACHEGPR119WNT1GSK3B
SCHEMBL16777532 0.87 HDAC4 (0.42) ACHEGPR119WNT1GSK3BDYRK1A
SCHEMBL15538948 0.87 HDAC4 (0.42) ACHEGPR119WNT1GSK3BDYRK1A
SCHEMBL15538783 0.87 WNT1 (0.40) ACHEGPR119WNT1GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 MAP4K4 2495/4885ACHE 4244/4885GPR119 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.